A Case of Malignant Proliferating Trichilemmoma of the Scalp with Multiple Metastases

Article information

Korean J Intern Med. 2001;16(1):40-43
*Department of Internal Medicine and Clinical Pathology Soonchunhyang University College of Medicine, Seoul, Korea
Address reprint requests to : Hee Sook Park, M.D., Department of Internal Medicine Soonchunhyang University Hospital 657 Hannam-dong, Yongsan-ku Seoul 140-743, Korea

Abstract

We report a case of malignant proliferating trichilemmal tumor showing multiple distant metastases. The patient demonstrated a round mass in the right occipital area for 12 months and the lesion grew rapidly to assume 8×6.5×4cm in diameter, with areas of superficial erosion and crusting within the recent 3 months. The entire lesion was removed with a wide surgical excision. It recurred on the neck area 4 months after excision and the lesion was removed with surgical resection again. There was evidence of multiple metastases on CNS and mediastinal lymph nodes after 6 months. The patient was treated with cisplatin and etoposide combination chemotherapy and a partial response was achieved.

Introduction

Malignant proliferating trichilemmoma is a rare neoplasm derived from the outer sheath of the hair follicle. This condition preferentially arises in areas of dense hair follicle concentration; therefore 90% occurs on the scalp. It is usually a solitary lesion and most commonly seen in elderly women. The usual clinical presentation is a subcutaneous cystic nodule that has been present for years and slowly progresses to a large, nodular mass, often following a history of trauma or inflammation.

Histologically, the growth is made up of a massive proliferation of the outer sheath epithelium, foci of trichilemmal keratinization, palisading nuclei on the peripheral side with nuclear atypia and surrounding tissue invasion. The lesion may lead to a false impression of squamous cell carcinoma due to the presence of cellular atypia, dyskeratotic cells and mitotic figures. While the majority of these neoplasms are considered biologically benign, there are rare reports of local recurrences and distant metastases13). We experienced a patient displaying a scalp lesion with multiple distant metastases, who achieved a partial response following combination chemotherapy.

Case Report

A 32-year-old Korean man had a large soft nodule on the right parietal scalp for 12 months. The lesion had been rapidly growing for the previous 3 months. It was covered with areas of superficial erosion and crusting. Upon examination, he appeared well overall but a round, subcutaneous, firm 8 cm-sized mass was palpated in the occipital scalp. No other regional lymphadenopathy was detected. Brain CT was performed (Figure 1). Additionally, under general anesthesia, a wide excision was performed with a 1cm margin. Frozen section examination of the margins confirmed adequate clearance. The biopsy specimen was diagnosed as a malignant proliferating trichilemmal tumor. The patient was hospitalized 4 months after wide excision due to a recurrence in the postauricular, suboc cipital area of a hard, fixed nodule measuring 2.5×1.0cm in maximal diameter. Aspiration cytology was accomplished, and the cytologic finding exhibited a metastatic malignant proliferative trichilemal tumor. Surgical extirpation was performed.

Figure 1.

Brain CT shows a relatively iso-dense lobulated mass at the outside of the skull in the right occipital area without intracranial involvement. However, tumor invasion to the periosteum and bone is questionable.

The patient revisited our clinic complaining of severe headache and nausea 6 months after surgical extirpation. Brain CT and chest CT were performed(Figure 2A, B). The brain CT imaging revealed a right superior cerebral, right inferior temporal-parietal parenchymal mass and a left superior frontoparietal scalp mass. Additionally, chest CT revealed multiple lymphatic metastases. The patient underwent partial resection of the tumor and a decompressive operation. He was treated with cisplatin (75mg/m2, day 1), etoposide(100/m2, days 1–3) combination chemotherapy, and achieved a partial response(Figure 3A, B). He has been followed up for 6 months without progression.

Figure 2.

A. Brain CT shows a right superior cerebral, right inferior temporal-parietal parenchymal mass and a left superior scalp mass.

B. Chest CT shows an enhancing mass in the right side of the pulmonary artery.

Figure 3.

A,B : The mass lesion in skull and chest has much improved as compared to the previous CT scan.

Histopathology

The excised specimen of the tumor consisted of an ovoid mass-like soft tissue, covered by an elipse of skin, measuring 8×6.5×4cm. Upon section, the cut surface of the mass is yellow-white and relatively homogeneous. The tumor is composed of a mainly lobular arrangement of large eosinophilic, sometimes clear squamoid cells and scattered small nests of small hyperchromatic round or somewhat spindle cells in a cellular and fibrotic stroma. The lobule of squamoid cells shows abrupt trichilemmal keratinization and eosinophilic necrosis in the center(Figure 4). The squamoid cells show marked nuclear pleomorphism and frequent mitoses(Figure 5). At the periphery of the lobule, there are transitions from large squamoid cells to small atypical hyperchromatic cells, or plump spindle cells. Immunochemistry was done in order to identify the origin of tumor cells. It disclosed positive staining for cytokeratin and epithelial membrane antigen(EMA) and negative staining for neuron-specific enolase (NSE) and chromogranin. The findings were consistent with a light microscopic diagnosis of malignant proliferating trichilemmal tumor.

Figure 4.

The epithelium in the center of the lobules abruptly changes into eosinophilic amorphous keratin(trichilemmal keratinization) (H-E stain × 200).

Figure 5.

The tumor consists of irregular shaped lobules of squamous epithelium. (H-E strain, × 100).

Discussion

The proliferative trichilemmal tumor is an uncommon neoplasm, derived from the outer root sheath of the hair follicle4). Brownstein and Arluk5) reported 50 patients, 84% of whom were women. In about 90% of all reported cases, the lesion is located on the scalp, with the remainder on the back, forehead, wrist and chest6). It usually consists of a solitary lesion and the usual clinical presentation is a subcutaneous cystic nodule that has been present for years and slowly progresses to a large, nodular mass, as a consequence of a history of trauma or chronic inflammation. Proliferating trichilemmal tumors can become large if neglected; a lesion as large as 25cm has been reported7).

Histologically, the growth is made up of massive proliferation of pilar sheath epithelium showing multiple central areas of trichilemmal keratinization and formation of homogeneous keratin cysts8). The tumor masses are surrounded by a layer of basaloid cells in which the tumor cell nuclei palisade and the cell membranes rest over an outer layer of PAS-reactive basement membrane9). Trichilemmal keratinization, as demonstrated by keratin foci without keratohyaline granules, usually is observed at the center of the cyst, and pale-staining, glycogen-rich clear cells also are a frequent finding. This is a peculiar form of cell maturation normally observed in the stratified epithelium of the outer root sheath of hair follicle5,6,1012). Occasional cells with hyperchromatic nuclei, mitotic figures and scattered dyskeratotic cells may be present, but these are not indicative of malignant transformation11). Saida and colleagues3) classified the oncological development of the trichilemmal type of tumor into three stages: 1)trichilemmal cyst, adenomatous stage: 2)proliferating trichilemmal cyst, epitheliomatous stage; and 3)malignant proliferating trichilemmal cyst, carcinomatous stage. Mehregan and Lee9) suggested that the malignant transformation of a proliferating trichilemmal tumor should be considered in cases of longstanding cystic and nodular lesions that demonstrate rapid growth or exophytic enlargement.

A truly malignant proliferating trichilemmal tumor is a rare incidence3). Amaral et al2) have reviewed seven cases of malignant proliferating trichilemmal tumors reported in the literature and added a case of their own with a lesion originating in the inguinal area and ending with pulmonary and liver metastasis.

In Korea, two cases13,14) have been reported. Both cases received surgical excision and one case14) received palliative radiotherapy. In our case, the tumor grew rapidly and metastasized to multiple distant sites following wide excision. The efficacy of chemotherapy in metastatic disease cannot be evaluated because of the small number of published cases. Weiss et al15) reported that one case responded to chemotherapy with cisplatin and fluorouracil. Our patient was treated with cisplatin and etoposide combination chemotherapy, and achieved a partial response. Malignant proliferating trichilemmal tumor is a rare disease and its pathogenesis has not been completely elucidated. We experienced a case of malignant proliferating trichilemmal tumor that showed a partial response to chemotherapy, suggesting that some of these tumors may respond to aggressive treatment with chemotherapy.

References

1. Holmes EJ. Tumors of lower hair sheath. Cancer 21:234–248. 1968;
2. Amaral AL, Nascimento AG, Goellner JR. Proliferating pilar(trichilemma) cyst. Arch Pathol Lab Med 108:808–810. 1984;
3. Saida T, Oohara K, Hori Y, Tsuchiya S. Development of a malignant proliferating trichilemmal cyst in a patient with multiple trichilemmal cysts. Dermatologica 166:203–208. 1983;
4. Leppard BJ, Sanderson KV. The natural history of trichilemmal cysts. Br J Dermatol 94:379–390. 1976;
5. Brownstein MH, Arluk DJ. Proliferating trichilemmal cyst: A stimulant of squamous cell carcinoma. Cancer 48:1207–1214. 1981;
6. Lever FW, Schauburg-Lever G. Histopathology of the skin p. 589–590. Philadelphia: JB Lippincott; 1990.
7. Casas J, Woscoff A. Giant pilar tumor of the scalp. Arch Dermatol 116:1395–1398. 1980;
8. Mehregan AH. Hair follicular tumors of the skin. J Cutan Pathol 12:189–195. 1985;
9. Mehregan AH, Lee KC. Malignant proliferting trichilemmal tumors-report of three cases. J Dermatol Surg Oncol 13:1339–1342. 1987;
10. Headinton JH. Tumors of the hair follicle. Am J Pathol 49:480–504. 1976;
11. Baptista AP, Silva LGE, Born MC. Proliferating trichilemmal cyst. J Cutan Pathol 10:178–187. 1983;
12. Laing V, Knipe RC, Flowers FP, Stoer CB, Ramos Caro FA. Proliferating trichilemmal tumor: report of a case and review of the literature. J Dermatol Surg Oncol 17:295–298. 1991;
13. Shin HJ, Woo SSH, Jeong JH. A case of malignant proliferating trichilemmoma of the scalp. Kor J Plast Surg 23:296–301. 1996;
14. Park BS, Yang SG, Cho KH. Malignant proliferating trichilemmal tumor showing distant metastases. Am J Dermatopathol 19(5):536–539. 1997;
15. Weiss J, Heine M, Grimmel M, Jung EG. Malignant proliferating trichilemmal cyst. J Am Acad Dermatol 32:870–873. 1995;

Article information Continued

Figure 1.

Brain CT shows a relatively iso-dense lobulated mass at the outside of the skull in the right occipital area without intracranial involvement. However, tumor invasion to the periosteum and bone is questionable.

Figure 2.

A. Brain CT shows a right superior cerebral, right inferior temporal-parietal parenchymal mass and a left superior scalp mass.

B. Chest CT shows an enhancing mass in the right side of the pulmonary artery.

Figure 3.

A,B : The mass lesion in skull and chest has much improved as compared to the previous CT scan.

Figure 4.

The epithelium in the center of the lobules abruptly changes into eosinophilic amorphous keratin(trichilemmal keratinization) (H-E stain × 200).

Figure 5.

The tumor consists of irregular shaped lobules of squamous epithelium. (H-E strain, × 100).